Cliodna A.M. McNulty* , Paul Boyle†, Tom Nichols‡, Douglas P. Clappison§, and Peter Davey¶
Author affiliations: *Health Protection Agency, Gloucester, United Kingdom; †University of Saint Andrews, Saint Andrews, United Kingdom; ‡Health Protection Agency, London, United Kingdom; §Southwold Surgery, Southwold, United Kingdom; ¶University of Dundee, Dundee, United Kingdom
Figure 2. Percentage of respondents with a leftover antimicrobial drug (all antimicrobial drugs, i.e., antibacterial plus antifungal drugs) by A) age (y) of respondent (p = 0.01, by test for trend) and B) no. of attitude questions answered incorrectly (p = 0.002, by test for trend). Error bars show 95% confidence intervals.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.